The EJP RD Final Conference “Consolidating the Rare Disease Research Ecosystem” is scheduled to take place from May 27th to May 28th, 2024 in Bari, Italy, this conference is set to bring together leading experts, professionals, and enthusiasts from around the world.Please note: the hybrid event is open in person only to invited people. The [...]
Based on the E6 ICH GCP guidelines, this training provides practical insights on implementing GCP principles. In just a few modules, you'll better understand your responsibilities when conducting clinical trials. Upon completing the training and passing a short quiz, you'll receive a certificate demonstrating your up-to-date GCP knowledge. With easy online access, interactive tools, and [...]
Mariagrazia Felisi, our Clinical Projects Director & Auditor, delivered an engaging lecture titled "Exploring Contract Research Organizations" at the clinical research workshop organized by the University of Florence's Placement Office on 6 February 2024. Boasting an impressive 25 years of hands-on experience in the realm of clinical research, Mariagrazia Felisi was selected as a speaker [...]
On Monday, 19 February 2024, at the EUCROF24 conference in Prague our Head of Development Area, Arianna Bertolani, takes the stage to present an abstract authored by three experts from CVBF: Giovanni Migliaccio, Irisi Sukaj and Arianna Bertolani. This abstract provides a concise yet comprehensive view of the challenges and opportunities in the submission process [...]
A new whitepaper published on 7 December 2023, in the Journal of Cell and Gene Therapy Insights is bringing attention to the big yet overlooked burden of faecal incontinence (FI) and proposing cell therapy as a transformative solution. The paper spotlights how cell therapy could provide a minimally invasive, curative option for FI patients compared [...]
Newsletter, December 2023 Starting the new year in a larger, more accessible office at Viale Cesare Battisti 17, Pavia (IT), CVBF embodies growth in space, identity and market. Our refreshed logo, maintaining our heritage in the acronym, now represents our global inclusivity as Clinical Validation from Biopharmaceutical Findings. Starting January 2024, we welcome you [...]
On 20 December 2023, Donato Bonifazi, our CEO, has been selected as a permanent member of the Advisory Group of the ACT EU Multistakeholder Platform (MSP AG), as a representative of the TEDDY Network, the European Network of Excellence for Paediatric Research. The platform is a result of Accelerating Clinical Trials in the EU (ACT EU), [...]
CVBF has achieved a major milestone by securing a significant role in the Horizon Europe-funded ERAMET project. Guided by Prof Adriana Ceci, the Lead Scientist of ERAMET for FGB-CVBF, this project is set to transform paediatric and orphan drug development. CVBF contribution is important as we will provide the expertise to enable the adoption of [...]
A new international clinical trial is underway across Europe to test whether low-dose atropine eye drops can effectively slow the progression of myopia (nearsightedness) in children and adolescents. The 40-month study, known as the MODERATO, is being conducted in children ages 3 to less than 18 with progressive myopia. Myopia occurs when the eyeball grows [...]
CVBF provides regulatory, site management, and monitoring support for the AMELIE (Anchored Muscle cELls for IncontinencE) project, Ana Dilo as our Clinical Project Manager of the study oversees and coordinates these activities. AMELIE is a collaborative study funded under the European Union's Horizon 2020 programme that aims to develop new treatments for faecal incontinence using [...]
